Journal article icon

Journal article

Comparing the safety and immunogenicity of a candidate TB vaccine MVA85A administered by intramuscular and intradermal delivery

Abstract:

Background: New vaccines to prevent tuberculosis are urgently needed. MVA85A is a novel viral vector TB vaccine candidate designed to boost BCG-induced immunity when delivered intradermally. To date, intramuscular delivery has not been evaluated. Skin and muscle have distinct anatomical and immunological properties which could impact upon vaccine-mediated cellular immunity. Methods: We conducted a randomised phase I trial comparing the safety and immunogenicity of 1×108pfu MVA85A delivered in...

Expand abstract

Actions


Access Document


Authors


Harris, SA More by this author
Poulton, ID More by this author
Poyntz, HC More by this author
Expand authors...
Journal:
Vaccine
Volume:
31
Issue:
7
Pages:
1026-1033
Publication date:
2013-02-04
DOI:
EISSN:
1873-2518
ISSN:
0264-410X
URN:
uuid:f44efa7d-1504-4e31-aae5-234ed8cc0450
Source identifiers:
379459
Local pid:
pubs:379459
Language:
English
Keywords:

Terms of use


Metrics



If you are the owner of this record, you can report an update to it here: Report update to this record

TO TOP